Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus

Diabetologia

Volumn 45, Issue 4, 2002, Pages 550-555

  Omoto, S ^a   Nomura, S ^a   Shouzu, A ^a   Nishikawa, M ^a   Fukuhara, S ^a   Iwasaka, T ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Activated platelets; Monocyte derived microparticle; Platelet derived microparticle; Soluble E selectin; Type II diabetes mellitus

Indexed keywords

CD63 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; PADGEM PROTEIN; BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; BLOOD; BODY MASS; COMPARATIVE STUDY; MIDDLE AGED; MONOCYTE; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; REGRESSION ANALYSIS; THROMBOCYTE; ULTRASTRUCTURE;

ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD PLATELETS; BODY MASS INDEX; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; HUMAN; MALE; MIDDLE AGE; MONOCYTES; PLATELET ACTIVATION; REFERENCE VALUES; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED;

EID: 0035988193     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0772-7     Document Type: Article

References (47)

1. Factor VIII complex in uraemia and effects of haemodialysis
2. Accumulation of lipoprotein remnants in patients with chronic renal failure
3. Immune mechanisms of atherosclerosis in diabetes mellitus
4. Coagulation and fibrinolytic system impairment in insulin dependent diabetes melliyus
5. Atherosclerosis, the major complication of diabetes
6. Ten years cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type II (non-insulin-dependent) diabetic and non-diabetic subjects
7. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells
8. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control
9. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
10. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress
11. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus
12. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes
13. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy
14. Significance of chemokines and activated platelets in patients with diabetes
15. Monocytes and macrophages
16. The pathogenesis of atherosclerosis: A perspective study for the 1990s
17. Mechanisms of monocyte recruitment and accumulation
18. Monocyte adherence to human vascular endothelium
19. Regional accumlation of Tcells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
20. Functional tissue factor is entirely surface expressed on lipopolysaccharide stimulated human blood monocytes and a constitutively tissue factor producing neoplastic cell line
21. Localization of tissue factor in normal vessel wall and in the atherosclerotic plaque
22. The molecular basis of blood coagulation
23. Procoagulant and profibrinolytic activities of cryopreserved human monocytes
24. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide
25. Endothelial cell activation by leukocyte microparticles
26. Endotoxin enhances the expression of monocyte prothrombinase activity
27. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques
28. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation
29. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM-1, and E-selectin in human atherosclerosis
30. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease
31. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
32. Differences between platelet and microparticle glycoprotein IIb/IIIa
33. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease
34. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation
35. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry
36. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody
37. Annexin V expression and membrane vesiculation during activation of leukemic cell lines
38. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
39. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene
40. Effects of troglitazone on blood concentrations of plasminogen activator 1 in patients with type 2 diabetes and in lean and obese normal subjects
41. The role of platelets in the development and complications of atherosclerosis
42. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity
43. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets
44. Adhesion receptors of the immune system
45. Endothelial-leukocyte adhesion molecules
46. Atheroma: More than mush